Humacyte, Inc. (HUMAW) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 151.91M |
| Enterprise Value | 166.26M |
| P/E Ratio | -1.18 |
| PEG Ratio | 0.01 |
| Price/Sales Ratio | 47.64 |
| Price/Book Ratio | 4.51 |
| Enterprise/Revenue | 41.17 |
| Enterprise/EBITDA | -1.1 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | -45.61 |
| Operating Margin | -52.41 |
AD
Management Effectiveness
| Return On Assets | -0.7 |
| Return On Equity | -9.38 |
Income Statement
| Revenue | 2.04M |
| Revenue/Share | 0.01 |
| Gross Profit | -15.01M |
| EBITDA | -22.24M |
| Net Income | -40.83M |
| Diluted EPS | -0.26 |
Balance Sheet
| Total Cash | 79.9M |
| Total Cash/Share | 0.34 |
| Total Debt | 66.18M |
| Total Debt/Equity | 2.12 |
| Current Ratio | 6.21 |
| Book Value Per Share | 0.13 |
Price History
| 52-Week Change | -99.57 |
| 52-Week High | 0.23 |
| 52-Week Low | 0 |
| Moving Average 50 Days | 0.01 |
| Moving Average 200 Days | 0.09 |
Statistics
| Average Volume | 25,607 |
| Shares Outstanding | 1.2B |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
